PMID- 2354408 OWN - NLM STAT- MEDLINE DCOM- 19900726 LR - 20220316 IS - 0008-543X (Print) IS - 0008-543X (Linking) VI - 66 IP - 1 DP - 1990 Jul 1 TI - Patterns of failure after curative resection of pancreatic carcinoma. PG - 56-61 AB - Thirty-six patients underwent curative resection of a primary pancreatic carcinoma from January 1977 to September 1987; 26 had Whipple resections, seven had total pancreatectomies, and three had distal pancreatectomies. Twenty-six patients manifested recurrent disease, four died of intercurrent disease, and six were apparently cured. Median survival was 11.5 months with actuarial survival at 2 and 5 years of 32% and 17%, respectively. Of the eventual recurrences, 19% were local only (pancreatic bed, regional nodes, adjacent organs, and immediately adjacent peritoneum) and 73% had a component of local failure. All patients failing did so with a component in the intraabdominal cavity. Peritoneal (42%) and hepatic failures (62%) were common. Extraabdominal metastases were documented in only 27%, but never as a sole site. Fourteen patient and tumor characteristics were evaluated for any relationships with failure or survival. No single variable independently predicted for local failure. However, a group of three (age greater than 60 years, T2 or T3 stage, and location of tumor in the body or tail) was associated with a substantial local failure risk (85% of all patients with local failure). Multivariate analysis showed that low tumor grade (P = 0.002), female sex (P = 0.002), and adjuvant radiation (P = 0.02) were all independent predictors of prolonged survival. Ten patients were treated in an adjacent setting. Those given 55 Gy or greater had improved local control (50% versus 25%) and cure (33% versus none) when compared with patients treated to lower doses. The authors conclude that local failure after curative resection remains a significant problem and further efforts to improve local control are warranted. However, peritoneal and hepatic relapses occur frequently. Thus, adjuvant treatment strategies using wide-field radiation techniques or intraperitoneal therapy, in combination with local tumor bed irradiation and chemotherapy, should be explored. FAU - Griffin, J F AU - Griffin JF AD - Department of Radiation Oncology, Kansas University Medical Center, Kansas City 66103. FAU - Smalley, S R AU - Smalley SR FAU - Jewell, W AU - Jewell W FAU - Paradelo, J C AU - Paradelo JC FAU - Reymond, R D AU - Reymond RD FAU - Hassanein, R E AU - Hassanein RE FAU - Evans, R G AU - Evans RG LA - eng GR - CA-12644/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Cancer JT - Cancer JID - 0374236 SB - IM MH - Adenocarcinoma/mortality/pathology/*surgery MH - Adult MH - Aged MH - Aged, 80 and over MH - Female MH - Humans MH - Male MH - Middle Aged MH - Pancreatic Neoplasms/mortality/pathology/*surgery MH - Retrospective Studies EDAT- 1990/07/01 00:00 MHDA- 1990/07/01 00:01 CRDT- 1990/07/01 00:00 PHST- 1990/07/01 00:00 [pubmed] PHST- 1990/07/01 00:01 [medline] PHST- 1990/07/01 00:00 [entrez] AID - 10.1002/1097-0142(19900701)66:1<56::aid-cncr2820660112>3.0.co;2-6 [doi] PST - ppublish SO - Cancer. 1990 Jul 1;66(1):56-61. doi: 10.1002/1097-0142(19900701)66:1<56::aid-cncr2820660112>3.0.co;2-6.